Skip to main content
. 2021 Aug 8;43(1):103170. doi: 10.1016/j.amjoto.2021.103170

Fig. 1.

Fig. 1

SARS-CoV-2 seroprevalence (serum IgG positivity) and SARS-CoV-2 RNA detectability (nasopharyngeal swab positivity) at T0, T1, T2 and T3.